Sanyatti
Member
The Pharmacy and Poisons Board (PPB) has given Emergency Use Approv
Kenya confirmed Wednesday it had approved emergency use of Russia’s Sputnik V CPVOD-19 vaccine for emergency use.
The approval comes barely two weeks after the government launched a nationwide vaccination drive for AstraZeneca vaccine whose eficacy has been questioned by experts leading to suspension by several countries in Europe. South Africa and the Democratic Republic of Congo have also paused its use.
On Wednesday, the Pharmacy and Poisons Board said it had approved Sputnik V vaccine.
“Yes, he application for Emergency Use Authorization has been evaluated and approved,” the board said in a statement, that warned “Note: this is not a registration.”
On whether Kenya plans to purchase the vaccine, the board said, “The Pharmacy and Poisons Board role is the authorization and safety monitoring of medicines and health technologies. It’s the duty of the Ministry of Health as guided by the National Vaccine and immunization programme to determine what vaccine (s) to buy based on factors, such as, cost and cold chain considerations.”
Russia has developed three vaccines — Sputnik V, EpiVacCorona and CoviVac — though most of the attention has focused on Sputnik, named after the first satellite launched into space by the Soviet Union.
The vaccine has been registered under the emergency use authorization procedure and is is one of only three vaccines in the world with an efficacy of over 90 percent.
Currently, Kenya is using the AstraZeneca vaccine which has an efficacy of 62 percent and over 40,000 Kenyans have so far received the jab.
al for Covid-19 vaccine (Sputnik V) in Kenya
#SputnikVaccineLifeSaver
Kenya confirmed Wednesday it had approved emergency use of Russia’s Sputnik V CPVOD-19 vaccine for emergency use.
The approval comes barely two weeks after the government launched a nationwide vaccination drive for AstraZeneca vaccine whose eficacy has been questioned by experts leading to suspension by several countries in Europe. South Africa and the Democratic Republic of Congo have also paused its use.
On Wednesday, the Pharmacy and Poisons Board said it had approved Sputnik V vaccine.
“Yes, he application for Emergency Use Authorization has been evaluated and approved,” the board said in a statement, that warned “Note: this is not a registration.”
On whether Kenya plans to purchase the vaccine, the board said, “The Pharmacy and Poisons Board role is the authorization and safety monitoring of medicines and health technologies. It’s the duty of the Ministry of Health as guided by the National Vaccine and immunization programme to determine what vaccine (s) to buy based on factors, such as, cost and cold chain considerations.”
Russia has developed three vaccines — Sputnik V, EpiVacCorona and CoviVac — though most of the attention has focused on Sputnik, named after the first satellite launched into space by the Soviet Union.
The vaccine has been registered under the emergency use authorization procedure and is is one of only three vaccines in the world with an efficacy of over 90 percent.
Currently, Kenya is using the AstraZeneca vaccine which has an efficacy of 62 percent and over 40,000 Kenyans have so far received the jab.
al for Covid-19 vaccine (Sputnik V) in Kenya
#SputnikVaccineLifeSaver
Attachments
Last edited: